Torray Investment Partners LLC Boosts Stock Holdings in UnitedHealth Group Incorporated $UNH

Torray Investment Partners LLC increased its position in UnitedHealth Group Incorporated (NYSE:UNH) by 3.6% in the fourth quarter, Holdings Channel.com reports. The fund owned 59,153 shares of the healthcare conglomerate’s stock after acquiring an additional 2,047 shares during the quarter. UnitedHealth Group makes up about 2.8% of Torray Investment Partners LLC’s holdings, making the stock its 14th biggest holding. Torray Investment Partners LLC’s holdings in UnitedHealth Group were worth $19,527,000 at the end of the most recent quarter.

Other large investors also recently modified their holdings of the company. Beacon Financial Strategies CORP bought a new position in shares of UnitedHealth Group in the fourth quarter valued at approximately $26,000. Foster Dykema Cabot & Partners LLC lifted its position in UnitedHealth Group by 69.4% during the third quarter. Foster Dykema Cabot & Partners LLC now owns 83 shares of the healthcare conglomerate’s stock valued at $29,000 after purchasing an additional 34 shares during the last quarter. 1248 Management LLC bought a new stake in UnitedHealth Group during the third quarter valued at approximately $29,000. Holos Integrated Wealth LLC bought a new stake in UnitedHealth Group during the fourth quarter valued at approximately $29,000. Finally, Hurley Capital LLC lifted its position in UnitedHealth Group by 81.6% during the third quarter. Hurley Capital LLC now owns 89 shares of the healthcare conglomerate’s stock valued at $31,000 after purchasing an additional 40 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors.

Key Stories Impacting UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Q1 beat and guidance raise — UNH reported a Q1 EPS beat and raised FY 2026 adjusted EPS guidance to above $18.25, citing improved medical-cost trends and revenue growth; that beat-and-raise is the primary driver of the intraday rally. UNH Q1 Deep Dive
• Positive Sentiment: Analyst upgrades and price‑target increases — Several firms (Argus, Morgan Stanley, RBC, Oppenheimer, Wells Fargo, Truist, Barclays, Jefferies) raised ratings or targets after the quarter, supporting further upside expectations. Analysts Increase Forecasts
• Positive Sentiment: Optum and AI investments as growth catalysts — Management outlined heavy investment in AI (about $1.5B) and growing throughput on the Optum Real claims platform, which management says will improve operating leverage and margins over time. UNH AI/Optum Real
• Positive Sentiment: Unusual bullish options activity — Elevated call volume (roughly 164k calls, ~30% above average) signals speculative and possibly institutional bullish positioning, which can amplify near‑term momentum.
• Neutral Sentiment: Market and media analysis — Multiple deep‑dive pieces and transcripts are out summarizing the quarter and management’s turnaround plan; useful for investors but largely restate the beat-and-raise. Earnings Call Transcript
• Negative Sentiment: Regulatory / program uncertainty — UnitedHealth flagged “challenges” with the Medicare obesity‑drug pilot program, creating uncertainty about future uptake or coverage that could affect medical costs or utilization. Reuters: Obesity Drug Pilot
• Negative Sentiment: Ongoing cost risk — Management and analysts still cite the risk that medical-cost trends could reaccelerate; investors should watch subsequent MCR (medical care ratio) prints and membership trends.
• Negative Sentiment: Not all analysts are uniformly bullish — One firm (Robert W. Baird) maintained an underperform stance with a lower target, a reminder that valuation and execution risk remain.

Wall Street Analysts Forecast Growth

A number of brokerages have recently weighed in on UNH. Argus upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $400.00 price objective for the company in a report on Wednesday. Wells Fargo & Company boosted their price objective on shares of UnitedHealth Group from $370.00 to $397.00 and gave the stock an “overweight” rating in a report on Wednesday. Robert W. Baird boosted their price objective on shares of UnitedHealth Group from $278.00 to $287.00 and gave the stock an “underperform” rating in a report on Wednesday. UBS Group lowered their price objective on shares of UnitedHealth Group from $430.00 to $410.00 and set a “buy” rating for the company in a report on Wednesday, January 28th. Finally, Royal Bank Of Canada lifted their target price on shares of UnitedHealth Group from $361.00 to $400.00 and gave the stock an “outperform” rating in a research note on Wednesday. One research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating, seven have assigned a Hold rating and two have given a Sell rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $377.68.

UnitedHealth Group Trading Up 0.1%

UnitedHealth Group stock traded up $0.52 during mid-day trading on Thursday, reaching $354.04. 1,171,634 shares of the company traded hands, compared to its average volume of 9,628,722. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.80 and a quick ratio of 0.79. The firm’s 50 day moving average price is $290.76 and its 200 day moving average price is $317.09. The firm has a market capitalization of $321.35 billion, a price-to-earnings ratio of 26.76, a P/E/G ratio of 1.53 and a beta of 0.40. UnitedHealth Group Incorporated has a 52-week low of $234.60 and a 52-week high of $429.90.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, April 21st. The healthcare conglomerate reported $7.23 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.76 by $0.47. The business had revenue of $111.65 billion for the quarter, compared to the consensus estimate of $109.84 billion. UnitedHealth Group had a net margin of 2.68% and a return on equity of 14.65%. The company’s quarterly revenue was up 2.0% compared to the same quarter last year. During the same period in the previous year, the firm earned $7.20 EPS. UnitedHealth Group has set its FY 2026 guidance at 18.250- EPS. On average, analysts anticipate that UnitedHealth Group Incorporated will post 18.43 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 17th. Stockholders of record on Monday, March 9th were given a $2.21 dividend. The ex-dividend date of this dividend was Monday, March 9th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.5%. UnitedHealth Group’s dividend payout ratio is currently 67.02%.

About UnitedHealth Group

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.